8-Benzyloxy-3’-deoxyguanosine
8-Benzyloxy-3’-deoxyguanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[2389988-57-0]
UNSPSC
12352005
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/8-benzyloxy-3-deoxyguanosine.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1C[C@@H](O)[C@H](N2C(OCC3=CC=CC=C3)=NC4=C2NC(N)=NC4=O)O1
Molecular Formula
C17H19N5O5
Molecular Weight
373.36
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Explore Other Products
Browse additional items from our catalog
CHO Monoclonal IL-17/IL-17A Antibody (vunakizumab) - Humanized - (Dry Ice)
NKX2-5 (NK2 Transcription Factor Related, locus 5 (Drosophila), CHNG5, CSX, CSX1, NKX2.5, NKX2E, NKX4-1) (HRP)
CDK5 Regulatory Subunit Associated Protein 3 (CDK5RAP3) Antibody